Impact of a Hospital Medication Expertise on Unplanned Hospitalizations at 3 Months of Nursing Homes Patients
Launched by ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE · Aug 17, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the involvement of hospital pharmacists can help reduce unplanned hospitalizations among elderly patients living in nursing homes. The researchers aim to improve medication management for older adults, who often take multiple medications that can lead to complications. By integrating pharmacists into care teams, they hope to ensure that medications are prescribed and managed safely, ultimately enhancing patient care and reducing the risks associated with medication use.
To be eligible for this trial, participants must be at least 65 years old, live in a nursing home, and have a higher risk of medication-related problems. They also need to be able to give consent, either themselves or through a trusted person. Participants can expect to receive careful evaluations of their medications by a team that includes both doctors and pharmacists. This study is important because it explores a collaborative approach to healthcare that could lead to better outcomes for older adults at risk of medication issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age greater than or equal to 65
- • Resident in EHPAD
- • presenting a high iatrogenic drug risk (Trivalle score between 6-10).
- • Ability to provide free, informed and express consent (patient and / or trusted person)
- • Affiliated to a social security scheme
- Exclusion Criteria:
- • Patient with a life expectancy \<3 months
- • Patient under 65 years
- • Trivale score \<6
- • Vulnerable persons within the meaning of French law (adults under guardianship or trusteeship, persons deprived of their liberty)
- • Participation in another research protocol in progress
- • Patient who has had a medication review (or medication review) known in the last 6 months.
- • Patient with severe dementia (MMSE \<18)
About Assistance Publique Hopitaux De Marseille
Assistance Publique - Hôpitaux de Marseille (AP-HM) is a leading public healthcare institution in France, dedicated to providing high-quality medical care and advancing research in various clinical fields. As a prominent sponsor of clinical trials, AP-HM is committed to fostering innovation and improving patient outcomes through rigorous scientific investigation. With a multidisciplinary approach, the institution collaborates with a network of healthcare professionals, researchers, and academic partners to facilitate cutting-edge studies that address critical health challenges. AP-HM's dedication to ethical standards and patient safety underscores its role as a trusted leader in clinical research and healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marseille, Paca, France
Patients applied
Trial Officials
EMILIE GARRIDO PRADALIE, MD
Study Director
APHM
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials